December 05, 2013
A Pennsylvania federal judge on Monday dismissed a man's lawsuit against Bristol-Myers Squibb Co. over a movement disorder he developed after taking the drug Abilify, saying that drugmakers are not required to provide detailed instructions to physicians about monitoring for adverse reactions.